• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Martin Makary FDA Senate HELP confirmation
Pharma

FDA's embattled Marty Makary steps down as commissioner

Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending a brief but tumultuous tenure marked by mounting criticism from all sides.
Angus Liu May 12, 2026 2:30pm
pay deal hand over cash licensing transaction money

Rigel snags Veppanu license from Pfizer, Arvinas for $85M

May 12, 2026 11:35am
Primaryimage1jpg

Targeted Protein Degradation: Advancing Novel Modalities

Brought to you by SYNGENE INTERNATIONAL LTD
reducing people on team

BioMarin lays off staffers at recently-acquired Amicus

May 12, 2026 5:12pm
Samsung BiologicsCLD-heropng

Integrated CDO capabilities reduce early development complexity

Brought to you by Samsung Biologics
Close up shot of the target from a dart game

Alkermes’ Lumryz, from $2.4B Avadel buy, hits phase 3 mark in IH

May 12, 2026 11:45am
More News

RFK Jr. continues to quietly probe vaccine safety: NYT

May 12, 2026 11:36am

Eli Lilly pauses Indian obesity awareness campaign: report

May 12, 2026 11:27am

Biosimilar competiton takes big bite out of Bayer's Eylea sales

May 12, 2026 10:51am

EU advances Critical Medicines Act to safeguard drug supply

May 12, 2026 9:13am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings